hypochlorous acid has been researched along with cytarabine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aroua, N; Bosc, C; Bossis, G; Farge, T; Gotanègre, M; Guyonnet-Dupérat, V; Hosseini, M; Jarrou, L; Larrue, C; Mouchel, PL; Piechaczyk, M; Récher, C; Rezvani, HR; Sabatier, M; Saland, E; Sarry, JE; Zaghdoudi, S | 1 |
| Asaro, G; De Luca, A; Delfini, M; Guglielmi, G; Iavicoli, S; Sciubba, F; Spagnoli, M | 1 |
2 other study(ies) available for hypochlorous acid and cytarabine
| Article | Year |
|---|---|
Targeting Myeloperoxidase Disrupts Mitochondrial Redox Balance and Overcomes Cytarabine Resistance in Human Acute Myeloid Leukemia.
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Cell Line, Tumor; Cytarabine; Drug Resistance, Neoplasm; Gene Expression Profiling; Humans; Hypochlorous Acid; Leukemia, Myeloid, Acute; Membrane Potential, Mitochondrial; Mice; Mice, Inbred NOD; Mice, SCID; Mitochondria; Molecular Targeted Therapy; Neoplasm Proteins; Oxidation-Reduction; Oxidative Stress; Peroxidase; Reactive Oxygen Species; RNA, Neoplasm; RNA, Small Interfering; Transcriptome; Xenograft Model Antitumor Assays | 2019 |
Efficacy of sodium hypochlorite in the degradation antineoplastic drugs by NMR spectroscopy.
Topics: Antineoplastic Agents; Azacitidine; Carcinogens; Cytarabine; Decontamination; Drug Interactions; Ethanol; Fluorouracil; Humans; Hypochlorous Acid; Irinotecan; Magnetic Resonance Spectroscopy; Occupational Exposure; Preliminary Data; Sodium Chloride; Sodium Hypochlorite; Time Factors | 2020 |